Literature DB >> 21386935

Utilization of methylnaltrexone (relistor) for opioid-induced constipation in an oncology hospital.

Jack L Watkins1, Karen R Eckmann, Morgan L Mace, Jane Rogers, Ginger Langley, Wendy Smith.   

Abstract

Entities:  

Year:  2011        PMID： 21386935      PMCID： PMC3046621     

Source DB:  PubMed          Journal:  P T        ISSN： 1052-1372


× No keyword cloud information.
  11 in total

Review 1.  Assessing and managing opiate-induced constipation in adults with cancer.

Authors:  Susan C McMillan
Journal:  Cancer Control       Date:  2004 May-Jun       Impact factor: 3.302

2.  Controlling off-label medication use.

Authors:  Muriel R Gillick
Journal:  Ann Intern Med       Date:  2009-02-16       Impact factor: 25.391

3.  How to reduce prescribing errors.

Authors: 
Journal:  Lancet       Date:  2009-12-12       Impact factor: 79.321

4.  Alcohol withdrawal: development of a standing order set.

Authors:  Evanthia Riddle; Jeff Bush; Mary Tittle; Dimple Dilkhush
Journal:  Crit Care Nurse       Date:  2010-03-01       Impact factor: 1.708

Review 5.  Effects of radiation on the human gastrointestinal tract.

Authors:  J M Novak; J T Collins; M Donowitz; J Farman; D G Sheahan; H M Spiro
Journal:  J Clin Gastroenterol       Date:  1979-03       Impact factor: 3.062

6.  Hospital-wide impact of a standardized order set for the management of bacteremic severe sepsis.

Authors:  Steven W Thiel; Muhammad F Asghar; Scott T Micek; Richard M Reichley; Joshua A Doherty; Marin H Kollef
Journal:  Crit Care Med       Date:  2009-03       Impact factor: 7.598

7.  Methylnaltrexone for treatment of opioid-induced constipation in advanced illness patients.

Authors:  Neal Slatkin; Jay Thomas; Arthur G Lipman; George Wilson; Michelle L Boatwright; Charles Wellman; Donna S Zhukovsky; Richard Stephenson; Russell Portenoy; Nancy Stambler; Robert Israel
Journal:  J Support Oncol       Date:  2009 Jan-Feb

8.  Implementation of standard order sets for patient-controlled analgesia.

Authors:  Lynn Marie Weber; Virginia L Ghafoor; Pamela Phelps
Journal:  Am J Health Syst Pharm       Date:  2008-06-15       Impact factor: 2.637

9.  Methylnaltrexone for opioid-induced constipation in advanced illness.

Authors:  Jay Thomas; Sloan Karver; Gail Austin Cooney; Bruce H Chamberlain; Charles Kevin Watt; Neal E Slatkin; Nancy Stambler; Alton B Kremer; Robert J Israel
Journal:  N Engl J Med       Date:  2008-05-29       Impact factor: 91.245

Review 10.  Opioid-induced bowel dysfunction: prevalence, pathophysiology and burden.

Authors:  S J Panchal; P Müller-Schwefe; J I Wurzelmann
Journal:  Int J Clin Pract       Date:  2007-05-04       Impact factor: 2.503
View more
  3 in total

Review 1.  Opioid induced bowel disease: a twenty-first century physicians' dilemma. Considering pathophysiology and treatment strategies.

Authors:  Ankush Sharma; M Mazen Jamal
Journal:  Curr Gastroenterol Rep       Date:  2013-07

Review 2.  Emerging therapies for patients with symptoms of opioid-induced bowel dysfunction.

Authors:  Wojciech Leppert
Journal:  Drug Des Devel Ther       Date:  2015-04-16       Impact factor: 4.162

3.  Opioid-Induced Constipation: Cost Impact of Approved Medications in the Emergency Department.

Authors:  W Frank Peacock; Neal Slatkin; Patrick Gagnon-Sanschagrin; Jessica Maitland; Annie Guérin; George Joseph
Journal:  Adv Ther       Date:  2022-03-17       Impact factor: 3.845
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.